
Predictive Simulation in Pharma Production
Simulation Unlocks Capacity, Boosts Reliability, Drives Smarter Decisions

Simulation Unlocks Capacity, Boosts Reliability, Drives Smarter Decisions

Clear incentive for drug manufacturers to equip their production facilities with the capacity to process highly potent active pharmaceutical ingredients (HPAPIs). HPAPIs now account for 25% of all drugs produced globally, with some analysts projecting that it will reach a value of $40 billion by 2027.



















Oxea will present its extensive product portfolio for the paint and coatings industry at this year's European Coatings Show (ECS), April 21 to 23, in Nuremberg, Germany.

